| A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer RM Goldberg, DJ Sargent, RF Morton, CS Fuchs, RK Ramanathan, ... Journal of Clinical Oncology 22 (1), 23-30, 2004 | 2977 | 2004 |
| Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest … AA Forastiere, B Metch, DE Schuller, JF Ensley, LF Hutchins, P Triozzi, ... Journal of Clinical Oncology 10 (8), 1245-1251, 1992 | 922 | 1992 |
| Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741 HK Sanoff, DJ Sargent, ME Campbell, RF Morton, CS Fuchs, ... Journal of Clinical Oncology 26 (35), 5721, 2008 | 397 | 2008 |
| Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741 HL McLeod, DJ Sargent, S Marsh, EM Green, CR King, CS Fuchs, ... Journal of Clinical Oncology 28 (20), 3227, 2010 | 285 | 2010 |
| Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with … RM Goldberg, DJ Sargent, RF Morton, CS Fuchs, RK Ramanathan, ... J Clin Oncol 24 (21), 3347-3353, 2006 | 262 | 2006 |
| Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144 SR Smalley, JK Benedetti, SK Williamson, JM Robertson, NC Estes, ... Journal of Clinical Oncology 24 (22), 3542-3547, 2006 | 237 | 2006 |
| Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non–small-cell lung cancer: a model for assessing population-related pharmacogenomics DR Gandara, T Kawaguchi, J Crowley, J Moon, K Furuse, M Kawahara, ... Journal of clinical oncology 27 (21), 3540, 2009 | 235 | 2009 |
| Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741 T Delaunoit, SR Alberts, DJ Sargent, E Green, RM Goldberg, J Krook, ... Annals of Oncology 16 (3), 425-429, 2005 | 225 | 2005 |
| Unemployment insurance with moral hazard in a dynamic economy C Wang, S Williamson Carnegie-Rochester Conference Series on Public Policy 44, 1-41, 1996 | 225 | 1996 |
| Disease control rate at 8 weeks predicts clinical benefit in advanced non–small-cell lung cancer: results from Southwest Oncology Group randomized trials PN Lara Jr, MW Redman, K Kelly, MJ Edelman, SK Williamson, ... Journal of Clinical Oncology 26 (3), 463-467, 2008 | 203 | 2008 |
| Tirapazamine: a novel agent targeting hypoxic tumor cells SB Reddy, SK Williamson Expert opinion on investigational drugs 18 (1), 77-87, 2009 | 180 | 2009 |
| Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non–small-cell lung cancer: Southwest Oncology Group Trial S0003 SK Williamson, JJ Crowley, PN Lara Jr, J McCoy, DHM Lau, RW Tucker, ... Journal of Clinical Oncology 23 (36), 9097-9104, 2005 | 147 | 2005 |
| Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest … SK Williamson, D Lew, GJ Miller, SP Balcerzak, LH Baker, ED Crawford Cancer: Interdisciplinary International Journal of the American Cancer …, 2000 | 142 | 2000 |
| High dose parenteral ascorbate inhibited pancreatic cancer growth and metastasis: mechanisms and a phase I/IIa study K Polireddy, R Dong, G Reed, J Yu, P Chen, S Williamson, PC Violet, ... Scientific reports 7 (1), 17188, 2017 | 140 | 2017 |
| Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420 SK Williamson, J Moon, CH Huang, PP Guaglianone, M LeBlanc, GT Wolf, ... Journal of Clinical Oncology 28 (20), 3330, 2010 | 136 | 2010 |
| N9741: oxaliplatin (oxal) or CPT-11+ 5-fluorouracil (5FU)/leucovorin (LV) or oxal+ CPT-11 in advanced colorectal cancer. Initial toxicity and response data from a GI Intergroup … R Goldberg Proc. Am Soc Clin Oncol 21, 128a (# 511), 2002 | 118* | 2002 |
| Lower osteopontin plasma levels are associated with superior outcomes in advanced non–small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG study S0003 PC Mack, MW Redman, K Chansky, SK Williamson, NC Farneth, ... Journal of clinical oncology 26 (29), 4771, 2008 | 117 | 2008 |
| Treatment of vitamin D deficiency in patients with metastatic prostate cancer may improve bone pain and muscle strength PJ VAN VELDHUIZEN, SA TAYLOR, S WILLIAMSON, BM DREES The Journal of urology 163 (1), 187-190, 2000 | 114 | 2000 |
| Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene M Kusumoto, S Umeda, A Ikubo, Y Aoki, O Tawfik, R Oben, S Williamson, ... Cancer Immunology, Immunotherapy 50, 373-381, 2001 | 92 | 2001 |
| Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741 GK Dy, JE Krook, EM Green, DJ Sargent, T Delaunoit, RF Morton, ... Journal of clinical oncology 25 (23), 3469-3474, 2007 | 88 | 2007 |
